Health and the 2024 US Election
Nicole Huberfeld, JD; Elizabeth McCuskey, JD; Michael R. Ulrich, JD, MPH
JAMA. 2024;332(17):1421-1422. doi:10.1001/jama.2024.19952
This Viewpoint examines how the outcome of the 2024 US presidential election could affect the future of medicine and public health, particularly the antimedicine proposals found in the Republican Party鈥檚 Project 2025 playbook.
Adam L. Beckman, MD, MBA; Joshua Jacobs, BA; Shereef M. Elnahal, MD, MBA
JAMA. 2024;332(17):1423-1424. doi:10.1001/jama.2024.16013
This Viewpoint examines the implementation of the Sergeant First Class Heath Robinson Honoring Our Promise to Address Comprehensive Toxics Act, known as the PACT Act, which expanded health care for millions of veterans from any era exposed to toxic hazards.
Joseph J. Palamar, PhD; Alex J. Krotulski, PhD
JAMA. 2024;332(17):1425-1426. doi:10.1001/jama.2024.15992
This Viewpoint discusses the spread of medetomidine in the US illicit opioid market and the need for monitoring and a public health response.
AI in Medicine
K. Casey Lion, MD, MPH; Yu-Hsiang Lin, MD; Theresa Kim, MD
free access
JAMA. 2024;332(17):1427-1428. doi:10.1001/jama.2024.15296
This Viewpoint discusses the challenges to implementing artificial intelligence鈥揵ased translation in clinical settings and what health care organizations can do to mitigate these challenges.